Home » Translational Medicine » Translational Medicine Operations Hub (TMOH)

Translational Medicine Operations Hub (TMOH)

TMOH offers the infrastructure to support translational medicine research.


The Translational Medicine Operations Hub (TMOH) ensures full research support from the operational planning of the study to their execution and closure via the collection, processing, storage and analysis of high-quality biological samples and structured clinical data.

The Translational Medicine Operations Hub (TMOH) includes the operational units of the LIH (CPMO, CIEC, CCMS, IBBL) and its collaborative platforms (LCTR, DMSP, LuxGen, RPP) to integrate and optimise their accessibility, workflows and project/portfolio oversight.

The TMOH provides the infrastructure to intra-institutional research, as well as transversal translational projects of “Research Luxembourg” and collaborations with external partners. These include publicly funded Research Projects like LITMUS, NCER-PD and CLINNOVA, as well as collaborations with industry partners. The central contact point of TMOH is the CPMO, which will guide researchers and their projects through the TMOH processes, as well as plan and track project execution.

As part of its mission, the TMOH hopes to improve patients’ lives by providing Operational Excellence:

Director of department 

The Department was established in July 2021, and Dr Hermann Thien was appointed as its Director. Hermann gained over 20 years of experience in the Pharmaceutical and Diagnostics Industry before joining LIH in March 2021.


Projects & clinical trials

Scientific publications

LIH researchers strive to generate meaningful and disease-relevant knowledge and results for patients. Their findings are regularly published in prestigious international peer-reviewed journals, thereby extending the reach and visibility of the institute’s impact.

Related News